MondayFeb 08, 2021 2:26 pm

RYAH Group Inc. Well Positioned as Data Continues to Shape Future of Medical Research

Recent article finds that data remains one of main drivers of medical research in 2021. New technologies employing AI powered by big data provide new solutions for tackling health problems, expand possibilities of clinical research RYAH combines power of devices combined with data to impact future of medical research to advance treatment of various medical conditions A recent Becker’s Hospital Review article cites 10 emerging trends in health IT that will shape this field in 2021, reporting that big data management is becoming a need as the use of artificial intelligence (“AI”) and machine learning in healthcare continues to blossom (https://ibn.fm/bMPIY).…

Continue Reading

MondayFeb 08, 2021 1:17 pm

2021 Strategic Plan Showcases API Potential of XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

XPhyto Therapeutics Corp. is a life sciences technology accelerator involved in the development of new pharmaceuticals, diagnostic products and psychedelic investments XPhyto is preparing a series of clinical pilot studies for four drug candidates this year that could help in treating Parkinson’s disease, epilepsy, anorexia and other neurological conditions The company has developed a rapid and highly portable PCR test kit it expects to commercialize this year to provide point-of-care diagnostics, designed for satellite labs to quickly screen for the COVID-19 virus Wholly owned subsidiary Vektor, a German drug maker and researcher, plans to build a new commercial drug manufacturing…

Continue Reading

MondayFeb 08, 2021 1:00 pm

New Discovery May Revolutionize the Treatment of Diabetes

A recent study conducted by researchers from the German Center for Diabetes Research, the Technical University of Munich and the Helmholtz Zentrum München has found a new and druggable insulin inhibitory receptor called inceptor. The study is a remarkable discovery for research on diabetes as the scientific community celebrates 50 years since the discovery of the insulin receptor and 100 years since the discovery of insulin. The researchers found that blocking inceptor function led to increased sensitization of the insulin signaling pathway. This, they said, may allow the regeneration and protection of beta cells for diabetes remission. Diabetes mellitus is…

Continue Reading

MondayFeb 08, 2021 12:11 pm

Predictive Oncology Inc. (NASDAQ: POAI) Stands to Benefit from Explosive Growth of Precision Medicine

Precision medicine in oncology allows for clinicians to develop personalized cancer treatment plans using individual characteristics of each patient Doctors use insights drawn from laboratory-grown cancer cells, patients’ DNA to individualize cancer treatment Predictive Oncology has been forerunner in its field, both through Helomics division’s smart tumor profiling platform as well as TumorGenesis subsidiary, which creates the tools used in ovarian cancer research TumorGenesis has begun to commercialize intellectual property, having received first order for unique ovarian cancer cell culture media in June 2020 In the summer of 2018, 49-year-old Star Dolbier arrived at the University of Maryland Greenebaum Cancer…

Continue Reading

FridayFeb 05, 2021 1:43 pm

Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Proprietary System Could Help Reduce Bladder Cancer Recurrence

The current standard for bladder cancer visualization, white light, is over three decades old and used in 95% of the bladder cancer surgeries The recurrence rate of bladder cancer is more than 50% due to the inability to see clear margins in the white light surgical standard for visualization Imagin Medical Inc.’s proprietary i/Blue(TM) System changes the way that surgeons visualize bladder cancer with side-by-side imaging of white and blue light pictures on one screen Blue light procedures are capable of reducing recurrence rates by 12-43% depending on the type, stage, and grade of bladder cancer The global bladder cancer…

Continue Reading

FridayFeb 05, 2021 1:31 pm

Brain Scientific Inc. (BRSF) Helps Identify Decision Triggers in Super Bowl Ads and COVID-19 Ads

Using BRSF's EEG products, Marketing Brainology was able to identify the most effective method for dispensing COVID-19 messaging Collected invaluable data for the current pandemic as well as how to navigate the future Brain Scientific (OTCQB: BRSF) is focused on developing innovative and proprietary medical devices and software. As the company works to modernize brain diagnostics through cutting-edge tech, it has also collaborated with Marketing Brainology, a neuromarketing firm that uses neuroscience to understand consumer behavior. In 2019, Marketing Brainology conducted a test to measure Super Bowl advertisements' impact using the NeuroCap, disposable EEG headset and NeuroEEG, a 16-channel EEG…

Continue Reading

FridayFeb 05, 2021 11:30 am

Study Finds Post-Op Pain-Management Medication Doesn’t Have to Include Opioids

A team of researchers from Michigan Medicine-University of Michigan conducted a study on post-op pain management that involved 620 patients who had undergone operations in various hospitals across the state. For the study, patients had their use of painkillers tracked and then participated in surveys in the months following their surgeries. In the study, which was reported in “JAMA Surgery,” researchers noted that, prior to surgery, half of the patients were counselled on alternative treatments for pain management that did not involve opioids. A third of the patients in this particular group were not prescribed any opioids post-surgery while the…

Continue Reading

ThursdayFeb 04, 2021 4:23 pm

United Medical Equipment Business Solutions Network Inc. to Thrive as High-Filtration Masks Gain Traction; Doctors Call for National Hi-Fi Mask Initiative

Not all face masks equally effective; high-filter masks proven most powerful Doctors call for national hi-fi mask initiative to widely distribute masks to each household United Medical offers high-filter masks; positioned to capitalize on broader recognition of hi-fi masks Not all masks are created equals, states a recent Stat article, which underscores the importance of high-filtration (hi-fi) masks. The article, titled "Along with vaccine rollouts, the U.S. needs a National Hi-Fi Mask Initiative," states that hi-fi masks such as N95 masks are the most effective in protecting against COVID-19 (https://ibn.fm/l3FJc). As a company distributing a comprehensive line set of COVID-19…

Continue Reading

ThursdayFeb 04, 2021 11:44 am

Researchers Uncover Way to Regulate Blood Pressure Post-Spinal Cord Injury

Researchers from the University of Calgary have developed a platform that can be used to understand the mechanisms that cause blood pressure instability after a spinal cord injury. Their findings have led to the creation of spinal cord stimulators that can be used to link the autonomous regulation system of an individual’s body, thus controlling blood pressure without using drugs. Grégoire Courtine from the Swiss Federal Institute of Technology and Dr. Aaron Phillips from Cumming School of Medicine (“CSM”) at the University of Calgary, co-led the global study, whose results were reported in “Nature.” The study’s findings are life changing…

Continue Reading

ThursdayFeb 04, 2021 10:04 am

Brain Scientific Inc. (BRSF) Offers Possible Solution for Detecting and Studying Parkinson’s

Parkinsons is diagnosed through skilled observation of specialized neurologists Neurologist shortage could turn into public emergency EEGs may hold the key to clearer diagnosis of Parkinson's Every year an estimated 60,000 people in the United States are diagnosed with Parkinson's disease (PD) (https://ibn.fm/ca0nb). Symptoms develop slowly, often spanning years, and vary from person to person. For a long time, PD has been diagnosed through the skilled observation of a neurologist, but recent studies suggest the EEG to be a promising diagnostic tool (https://ibn.fm/zCRAz). Brain Scientific (OTCQB: BRSF) is on a mission of modernizing brain diagnostics through cutting-edge technologies, which could…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000